Quantcast

Latest Thrombosis Stories

2011-06-04 07:00:00

BRIDGEWATER, N.J., June 4, 2011 /PRNewswire/ -- Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%(i), meeting the study primary endpoint (respectively 1.2%...

2011-05-31 15:22:19

In a nationwide study, researchers at the Centre for Primary Health Care Research in Malmö, Sweden, have mapped the significance of hereditary factors in venous thromboembolism. Venous thromboembolism (VTE) is the third most common type of cardiovascular disease after coronary heart disease and stroke. Researchers at the Centre for Primary Health Care Research in Malmö have mapped the significance of hereditary factors for venous thromboembolism in the entire Swedish population by...

2011-05-31 07:00:00

WEST HILLS, California, May 31, 2011 /PRNewswire/ -- Medical Compression Systems (MCS), which is involved in the non-invasive medical device industry and traded on the TASE, announced today that it has received FDA clearance to market the ActiveCare+Dx (temporary name) device developed on the basis of its flagship product, ActiveCare+S.F.T.(R) The new product is the only one on the market which integrates venous obstruction prevention and detection capacities whereby both operations...

2011-05-27 13:03:38

Omega-3 fatty acids, combined with two blood-thinning drugs, significantly changed the blood-clotting process and may reduce the risk of heart attacks in patients with stents in their heart arteries, according to research reported in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association. Foods rich in omega-3, such as salmon and other oily fish, have been previously shown in other studies to reduce the risk of heart problems in people with coronary...

2011-05-24 09:00:00

Medication, movement can prevent DVT, pulmonary embolism CHICAGO, May 24, 2011 /PRNewswire-USNewswire/ -- Each year in the United States, pulmonary embolisms (PE) kill more people than AIDS, breast cancer and motor vehicle crashes combined. According to the American College of Foot and Ankle Surgeons, this little known condition occurs when a blood clot in the leg travels to the lungs, blocking one or more arteries. Most recently, news that tennis star Serena Williams suffered a PE after...

2011-05-06 08:52:00

BALTIMORE, May 6, 2011 /PRNewswire/ -- Stenting is safe and effective and superior to balloon angioplasty for treatment of venous stenosis in patients with deep vein thrombosis (DVT), according to results from EVISTA-DVT, presented today as a Late-Breaking Clinical Trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions in Baltimore. EVISTA-DVT focused on patients with blocked veins who had received clot-buster drug therapy (thrombolysis)....

2011-05-04 08:40:00

Knowing the Symptoms of DVT Can Save Your Life WASHINGTON, May 4, 2011 /PRNewswire-USNewswire/ -- As temperatures warm and travel picks up around the country, the nation's emergency physicians issue a warning about the serious dangers associated with deep vein thrombosis (DVT). This is a condition occurring when blood clots form in a vein located in a person's lower leg and thigh. (Logo: http://photos.prnewswire.com/prnh/20100616/DC22034LOGO-d) "DVT is very dangerous and can do severe...

2011-04-29 13:40:52

Being tall and obese may increase your risk for potentially dangerous blood clots, according to new research in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association. Obesity is a well-known risk factor for clots in deep veins (usually in the legs) and for pulmonary embolism, a clot in blood vessels of the lungs that can result in sudden death or strain on the heart. Together, the two conditions are called venous thromboembolism (VTE). Compared with...

2011-04-27 00:30:00

LEUVEN, Belgium and LUND, Sweden, April 27, 2011 /PRNewswire-FirstCall/ -- - Trial to Assess the Benefits of Partial Factor VIII Inhibition in Total Hip Replacement Surgery Patients ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce today that the first patient has been dosed in a Phase IIb trial with their novel long-acting anticoagulant TB-402 (Anti-Factor VIII) for the prophylaxis of venous thromboembolism (VTE)...

2011-04-22 07:30:00

TOKYO, April 22, 2011 /PRNewswire/ -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), announced today that the company has received its first marketing approval for LIXIANA® (JAN: Edoxaban Tosilate Hydrate, INN:edoxaban) 15 mg and 30 mg tablets, by the Ministry of Health, Labor and Welfare in Japan. Edoxaban, which is being developed solely by Daiichi Sankyo, is a once-daily, oral anticoagulant that specifically, reversibly and directly inhibits the enzyme,...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.